Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

NCT07025369 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Stage IIC Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Stage IV Prostate Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Flotufolastat F-18 Gallium
PROCEDURE: Laparoscopic Radical Prostatectomy with Robotics
PROCEDURE: Pelvic Lymphadenectomy
PROCEDURE: Positron Emission Tomography
DRUG: Relugolix

Sponsor

Mayo Clinic